The authors concluded that epidural corticosteroid injections had small, possibly not clinically significant, only shortterm effects on leg pain and disability, compared with placebo, in patients with sciatica. Not all the findings were included in the review and it was unclear what effect this might have had on the results. The reliability of the conclusions remains unclear.
Study selection
Eligible for inclusion were randomised controlled trials comparing the efficacy of epidural corticosteroid injections (caudal, interlaminar, or transforaminal) versus placebo in patients with sciatica or a synonym for sciatica, such as disc herniation. Trials had to report one of the following outcomes: overall pain intensity, leg pain intensity, back pain intensity, and disability status. Trials using a short-acting local anaesthetic were eligible if the anaesthetic was administered to all patients. Trials of patients with foraminal stenosis or lateral recess stenosis were eligible. Trials of patients who had received surgery or whose symptoms were due to spinal canal stenosis were excluded.
Included trials were published between 1970 and 2012 and, where reported, were conducted in hospitals, general or private practices, or military medical centres. Where reported, the mean age for the patient groups ranged from 37.3 to 52.8 years. Patients were classified by their symptoms being acute (less than six weeks), subacute (six to 12 weeks), chronic (12 weeks or more), or mixed. Epidural corticosteroids included methylprednisolone, prednisolone, triamcinolone, and betamethasone. Some trials provided additional interventions, such as analgesics, physiotherapy, or educational materials. Pain intensity was measured on visual analogue scales (zero to 100) or numeric rating scales (zero to 10). Disability was measured using the Oswestry Disability Index or Roland-Morris Questionnaire.
The authors did not state how many reviewers screened studies for inclusion.
Assessment of study quality
Two reviewers independently assessed the risk of bias in trails using the Physiotherapy Evidence Database (PEDro) scale, resulting in a score out of 10. Disagreements were resolved by a third reviewer. A modified version of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to summarise the overall quality of the evidence.
Data extraction
Two reviewers independently extracted mean differences and 95% confidence intervals, or means (final scores or change scores) and standard deviations. These data were extracted for follow-up at immediate term (two weeks or less after randomisation), short term (between two weeks and three months), intermediate term (between three months and 12 months), and long term (over 12 months).
Scores for pain intensity and disability were converted to scales from zero (no pain or disability) to 100 (worst possible pain or disability). Where data were missing, trial authors were contacted or data were estimated using the methods recommended by the Cochrane handbook.
